447
Participants
Start Date
March 5, 2019
Primary Completion Date
June 17, 2024
Study Completion Date
June 17, 2024
Biktarvy
Integrase inhibitor used to treat HIV-1 infection
Symtuza
Protease inhibitor used to treat HIV-1 infection
Institute of Tropical Medicine, Antwerp
CHU Saint-Pierre, Brussels
University Hospital Ghent, Ghent
Hopital Europeen Marseille, Marseille
Groupe Hospitalier Sud Ile-de-France (Melun), Melun
Hôpital Gui de Chauliac, Montpellier
CHU de Nantes, Nantes
Hopital Lariboisiere, Paris
Hopital Saint-Louis, Paris
Hôpital Saint Antoine, Paris
Pitié-Salpêtrière Hospital, Paris
Medizinische Klinik und Poliklinik Universitätsklinikum Bonn, Bonn
Goethe University Hospital Frankfurt, Frankfurt
ICH Study Center Gmbh & Co. KG, Hamburg
Medizinische Hochschule Hannover, Hanover
Klinikum rechts der Isar der Technischen Universität München, Munich
University Hospital Klinikum rechts der Isar der TUM, Munich
Mater Misericordiae University Hospital, Dublin
St Vincent's University Hospital, Dublin
Luigi Sacco Hospital, Milan
Ospedale San Raffaele, Milan
ASST Santi Paolo, Milan
Clinica of Infectious Diseases, Modena
INMI Lazzaro Spallanzani, Rome, Rome
Hospital General Universatario Alicante, Alicante
Hospital Clinic (Helios Building), Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital del Mar, Barcelona
Hospital Universitari Vall d'Herbon, Barcelona
Hospital General Universitatrio de Elche, Elche
Hospital Ramon y Cajal, Madrid
Hospital Universitatrio La Paz, Madrid
Royal Bournemouth Hospital, Bournemouth
Southmead Hospital, Bristol
Leeds Teaching Hospital, Leeds
Barts Health, London
Chelsea and Westminister, London
Guy's Hospital, London
Homerton University Hospital, London
Imperial College Healthcare Trust, London
Kings College London, London
Mortimer Market Centre, London
Royal Free Hospital, London
St George's Hospital, London
University Hospital Lewisham, London
North Manchester General Hospital, Manchester
Sheffield Teaching Hospital, Sheffield
Collaborators (2)
Gilead Sciences
INDUSTRY
Janssen Pharmaceuticals
INDUSTRY
NEAT ID Foundation
OTHER